No Increase in MS Disease Activity Due to COVID-19 : vimarsa

COVID-19 has no impact on disease activity, progression, or cognitive performance in patients with multiple sclerosis.

Related Keywords

Italy , Milan , Lombardia , Fondazione Italiana Sclerosi Multipla , Federico Montini , Medscape Coronavirus Resource Center , Coronavirus Resource , Expanded Disability Status Scale , Modified Fatigue Impact Scale , Hospital Anxiety , Depression Scale , Pittsburgh Sleep Quality Index , Event Scale Revised , San Raffaele Hospital , Fondazione Italiana Sclerosi , Multiple Sclerosis Ms , Multiple Sclerosis , Us , Multiple Sclerosis Progression , Als Progression , Multiple Sclerosis Treatment , Als Treatment , Reatment Of Multiple Sclerosis , Reatment Of Ms , Multiple Sclerosis Relapse , S Relapse , Elapse Of Multiple Sclerosis , Elapse Of Ms , Coronavirus , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , ,